1. Home
  2. RDW vs TLX Comparison

RDW vs TLX Comparison

Compare RDW & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redwire Corporation

RDW

Redwire Corporation

HOLD

Current Price

$11.04

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$11.32

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
TLX
Founded
2020
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.9B
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
RDW
TLX
Price
$11.04
$11.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$13.71
★ $21.13
AVG Volume (30 Days)
★ 10.8M
427.2K
Earning Date
05-08-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 2.98
N/A
EPS
N/A
★ N/A
Revenue
★ $335,381,000.00
N/A
Revenue This Year
$41.68
N/A
Revenue Next Year
$20.25
N/A
P/E Ratio
★ N/A
$150.33
Revenue Growth
★ 10.29
N/A
52 Week Low
$4.87
$6.28
52 Week High
$26.64
$13.11

Technical Indicators

Market Signals
Indicator
RDW
TLX
Relative Strength Index (RSI) 48.50 47.37
Support Level $9.99 $10.92
Resistance Level $11.50 $11.48
Average True Range (ATR) 0.67 0.40
MACD 0.05 -0.10
Stochastic Oscillator 45.43 24.90

Price Performance

Historical Comparison
RDW
TLX

About RDW Redwire Corporation

Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: